The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer.

Breast · 2020 · PMC7375582 · PMID 32497987

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This study showed a trend towards worse DFS for the subgroup of hormone receptor-negative BC patients with recovery of menstruation after chemotherapy (HR 1.73, 95% CI 0.86–3.48) [ 16 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.